Название продукции:3-Hydrazino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine

IUPAC Name:5-hydrazinyl-3,4-diazatricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaene

CAS:802598-74-9
Молекулярная формула:C13H14N4
Чистота:95%+
Номер в каталоге:CM337866
Молекулярная масса:226.28

Упаковочная единица Доступно для заказа Цена ($) Количество
CM337866-100mg in stock ŭǺƻ
CM337866-250mg in stock ƏœƩ
CM337866-1g 1-2 Weeks ŭŭƏƻ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:802598-74-9
Молекулярная формула:C13H14N4
Точка плавления:-
Smiles-код:NNC1=NN=C2C(CCCC3=CC=CC=C32)=C1
Плотность:
Номер в каталоге:CM337866
Молекулярная масса:226.28
Точка кипения:
Номер Mdl:
Хранение:2-8ºC

Column Infos

Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products